Relmada Therapeutics Inc.

NASDAQ: RLMD
Share price (1/8/25): $0.45
Market cap (1/8/25): $13.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Deep Track Capital, LP

Casamento Charles J

Traversa Sergio

Casamento Charles J

News Filter

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

To Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017 Relmada Therapeutics Has Commenced a Process to Explore Strategic Alternatives to Maximize Shareholder Value

The DMC Did Not Identify Any New Safety Concerns

Shareholder Vote Results, Financial Statements or Exhibits

Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC